cytarabine has been researched along with Child Development Deviations in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bearden, DR; Burrage, LC; Craigen, WJ; Emrick, L; Freeze, HH; Graham, BH; Jain, M; Lee, B; Ng, BG; Rosenfeld, JA | 1 |
Kaleita, TA; MacLean, WE; Reaman, GH; Sather, HN; Whitt, JK | 1 |
2 other study(ies) available for cytarabine and Child Development Deviations
Article | Year |
---|---|
Pathogenic Variants in Fucokinase Cause a Congenital Disorder of Glycosylation.
Topics: Amino Acid Sequence; Brain Diseases; Child; Congenital Abnormalities; Developmental Disabilities; Female; Fibroblasts; Fucosyltransferases; Genetic Variation; Glycosylation; Guanosine Diphosphate Fucose; Guanosine Diphosphate Mannose; Humans; Male; Muscle Hypotonia; Phosphotransferases (Alcohol Group Acceptor); Seizures; Sequence Alignment; Skin; Ubiquitin | 2018 |
Neurodevelopmental outcome of infants with acute lymphoblastic leukemia: a Children's Cancer Group report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Damage, Chronic; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Developmental Disabilities; Female; Follow-Up Studies; Humans; Infant; Injections, Spinal; Leucovorin; Leukemic Infiltration; Male; Mercaptopurine; Methotrexate; Movement Disorders; Neuropsychological Tests; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Psychomotor Performance; Remission Induction; Risk; Socioeconomic Factors; Survivors; Vincristine | 1999 |